Evidence map›Paper›PMID 32903101›Full record

ArticleHypertension (Dallas, Tex. : 1979)2020

Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension.

Daniel N Meijles, Joshua J Cull, Thomais Markou, Susanna T E Cooper, Zoe H R Haines, Stephen J Fuller, Peter O'Gara, Mary N Sheppard, Sian E Harding, Peter H Sugden and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Healing mechanisms of Galectin-1 in the ischemic heart.Cell biochemistry and biophysics · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. [Mechanism of Trifolin in Attenuating Hypertension-Induced Renal Cell Apoptosis via Modulation of the MAPK Signaling Pathway].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials.International journal of translational medicine (Basel, Switzerland) · 2025
    Article
  16. Article
  17. Quercetin improves heart failure by inhibiting cardiomyocyte apoptosisNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  18. Article
  19. Article
  20. Reactive oxygen species in hypertension.Nature reviews. Cardiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Daniel N MeijlesFrom the Molecular and Clinical Sciences Institute (D.N.M., S.T.E.C., Z.H.R.H.), St George's University of London, United Kingdom.
Joshua J CullSchool of Biological Sciences, University of Reading, United Kingdom (D.N.M., J.J.C., T.M., S.J.F., P.H.S., A.C.), St. George's Healthcare NHS Trust, London, United Kingdom.
Thomais MarkouSchool of Biological Sciences, University of Reading, United Kingdom (D.N.M., J.J.C., T.M., S.J.F., P.H.S., A.C.), St. George's Healthcare NHS Trust, London, United Kingdom.
Susanna T E CooperFrom the Molecular and Clinical Sciences Institute (D.N.M., S.T.E.C., Z.H.R.H.), St George's University of London, United Kingdom.
Zoe H R Haines
Stephen J FullerFrom the Molecular and Clinical Sciences Institute (D.N.M., S.T.E.C., Z.H.R.H.), St George's University of London, United Kingdom.
Peter O'GaraNational Heart and Lung Institute, Faculty of Medicine, Imperial College London, United Kingdom (P.O., S.E.H.).
Mary N SheppardCRY Cardiovascular Pathology Department (M.N.S.), St George's University of London, United Kingdom.
Sian E HardingNational Heart and Lung Institute, Faculty of Medicine, Imperial College London, United Kingdom (P.O., S.E.H.).
Peter H SugdenSchool of Biological Sciences, University of Reading, United Kingdom (D.N.M., J.J.C., T.M., S.J.F., P.H.S., A.C.), St. George's Healthcare NHS Trust, London, United Kingdom.
Angela ClerkSchool of Biological Sciences, University of Reading, United Kingdom (D.N.M., J.J.C., T.M., S.J.F., P.H.S., A.C.), St. George's Healthcare NHS Trust, London, United Kingdom.
St George’s University Hospitals NHS Foundation Trust · GBSt George's, University of London · GBLung Institute · US

Funding

British Heart Foundation FS/18/33/33621British Heart Foundation FS/19/24/34262British Heart Foundation PG/13/71/30460British Heart Foundation PG/15/24/31367British Heart Foundation PG/15/31/31393British Heart Foundation PG/17/11/32841Wellcome Trust 204809/Z/16/Z
6 · The paper itself

Abstract

Systemic hypertension increases cardiac workload causing cardiomyocyte hypertrophy and increased cardiac fibrosis. An underlying feature is increased production of reactive oxygen species. Redox-sensitive ASK1 (apoptosis signal-regulating kinase 1) activates stress-regulated protein kinases (p38-MAPK [mitogen-activated protein kinases] and JNKs [c-Jun N-terminal kinases]) and promotes fibrosis in various tissues. Here, we determined the specificity of ASK1 signaling in the heart, with the hypothesis that ASK1 inhibitors may be used to manage fibrosis in hypertensive heart disease. Using immunoblotting, we established that moderate levels of H

Indexed as

AnimalsBenzamidesHeartHydrogen PeroxideHypertensionImidazolesMAP Kinase Kinase Kinase 5MyocardiumMyocytes, CardiacOxidation-ReductionOxidative Stressp38 Mitogen-Activated Protein KinasesProtein Kinase InhibitorsPyridinesRatsReactive Oxygen SpeciesBenzamidesHydrogen PeroxideImidazolesMAP Kinase Kinase Kinase 5p38 Mitogen-Activated Protein KinasesProtein Kinase InhibitorsPyridinesReactive Oxygen Speciesselonsertibangiotensinheart diseasehypertensionoxidative stress reactive oxygen speciesprotein kinase

Identifiers

PMID32903101
PMCPMC7480944
OpenAlexW3083930173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.